Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Pharmacology   Volumes    Volume 17  Issue 1
Therapeutic approaches for the treatment of Frontotemporal Lobar Degeneration
Carolina Alquézar, Noemí Esteras, Ana de la Encarnación, Ángeles Martin-Requero
Pages: 85 - 101
Number of pages: 17
Current Topics in Pharmacology
Volume 17  Issue 1

Copyright © 2013 Research Trends. All rights reserved

Frontotemporal Lobar Degeneration (FTLD) is nowadays considered the second cause of dementia, accounting for 20% of all the cases under the age of 65 years. The earliest signs of frontotemporal dementia are a fundamental change in personality, social behavior, and communication abilities. The pathological and clinical heterogeneity of FTLD has made the application of effective therapies a difficult task. No treatments for FTLD are available yet, and off-label medications are commonly used as symptomatic drugs to counteract behavioral, cognitive and motor disturbances. In general, two different approaches to treat FTLD have been considered. First, treatments to improve clinical symptoms and second, disease-modifying therapies aimed at slowing disease progression by acting on molecular mechanisms, thought to be involved in FTLD pathogenesis. This brief review aims to highlight recent advances in the treatment of FTLD.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms